Literature DB >> 25725634

Clinical and laboratory characteristics of active and healthy aging (AHA) in octogenarian men.

Kirsi K Rantanen1, Timo E Strandberg2,3, Sari S Stenholm4,5,6, Arto Y Strandberg2, Kaisu H Pitkälä7, Veikko V Salomaa4,5, Reijo S Tilvis8.   

Abstract

OBJECTIVES: To investigate clinical and laboratory variables associated with good subjective and objective health ("active and healthy aging", AHA) in a cohort of octogenarian men.
DESIGN: Cross-sectional analyses of a longitudinal study.
SETTING: The Helsinki Businessmen Study in Finland. PARTICIPANTS: A socioeconomically homogenous cohort of men (baseline n = 3293), born in 1919-1934, has been followed up from the 1960s. From 2000, the men have been regularly sent mailed questionnaires and mortality has been retrieved from national registers. MEASUREMENTS: In 2010 survey, AHA was defined as independently responding to the mailed survey, feeling happy without cognitive or functional impairments and without major diseases. In 2010/11, a random subgroup men was clinically investigated and survivors with healthy and nonhealthy aging were compared.
RESULTS: By 2010, 1788 men of the baseline cohort had died, and 894 men responded to the mailed survey. 154 (17.2 %) of those fulfilled the present AHA criteria. Increasing number of criteria were negatively (P < 0.001) related to short-term mortality. In 2011, a random sample of 458 men were clinically investigated, 90 of them with AHA. Men with AHA had higher serum LDL cholesterol and diastolic blood pressure (partially explained by less frequent drug use) but no significant difference was observed in other risk factors. Men with AHA had significantly faster walking speed (P < 0.001), stronger handgrip (P = 0.017), better self-rated health and less phenotypic frailty (P = 0.02).
CONCLUSION: Less than 5 % enjoyed active and healthy aging over their life course, which was significantly related to markers of frailty but not to the traditional vascular risk factors.

Entities:  

Keywords:  Active and healthy aging; Compression of morbidity; Frailty; Longevity; Successful aging

Mesh:

Substances:

Year:  2015        PMID: 25725634     DOI: 10.1007/s40520-015-0329-0

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  4 in total

1.  SIRT6 polymorphism rs117385980 is associated with longevity and healthy aging in Finnish men.

Authors:  Katariina Hirvonen; Hannele Laivuori; Jari Lahti; Timo Strandberg; Johan G Eriksson; Peter Hackman
Journal:  BMC Med Genet       Date:  2017-04-11       Impact factor: 2.103

2.  The impact of muscle function, muscle mass and sarcopenia on independent ageing in very old Swedish men.

Authors:  Kristin Franzon; Björn Zethelius; Tommy Cederholm; Lena Kilander
Journal:  BMC Geriatr       Date:  2019-05-29       Impact factor: 3.921

3.  Major cardiovascular disease (CVD) risk factors in midlife and extreme longevity.

Authors:  Annele Urtamo; Satu K Jyväkorpi; Hannu Kautiainen; Kaisu H Pitkälä; Timo E Strandberg
Journal:  Aging Clin Exp Res       Date:  2019-10-14       Impact factor: 3.636

4.  Time-to-event modeling of hypertension reveals the nonexistence of true controls.

Authors:  Daniel Shriner; Amy R Bentley; Jie Zhou; Kenneth Ekoru; Ayo P Doumatey; Guanjie Chen; Adebowale Adeyemo; Charles N Rotimi
Journal:  Elife       Date:  2020-12-01       Impact factor: 8.140

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.